ALXN
Ameriprise’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-400,428
| Closed | -$73.6M | – | 4015 |
|
|
2021
Q2 | $73.6M | Sell |
400,428
-15,333
| -4% | -$2.82M | 0.02% | 634 |
|
|
2021
Q1 | $63.6M | Sell |
415,761
-1,934,982
| -82% | -$296M | 0.02% | 672 |
|
|
2020
Q4 | $367M | Sell |
2,350,743
-2,750,143
| -54% | -$430M | 0.13% | 167 |
|
|
2020
Q3 | $584M | Sell |
5,100,886
-935,750
| -16% | -$107M | 0.24% | 88 |
|
|
2020
Q2 | $677M | Sell |
6,036,636
-246,241
| -4% | -$27.6M | 0.29% | 68 |
|
|
2020
Q1 | $564M | Buy |
6,282,877
+60,799
| +1% | +$5.46M | 0.3% | 69 |
|
|
2019
Q4 | $673M | Buy |
6,222,078
+388,344
| +7% | +$42M | 0.28% | 70 |
|
|
2019
Q3 | $571M | Sell |
5,833,734
-497,940
| -8% | -$48.8M | 0.26% | 77 |
|
|
2019
Q2 | $829M | Sell |
6,331,674
-572,866
| -8% | -$75M | 0.37% | 45 |
|
|
2019
Q1 | $933M | Sell |
6,904,540
-87,752
| -1% | -$11.9M | 0.43% | 38 |
|
|
2018
Q4 | $681M | Sell |
6,992,292
-112,693
| -2% | -$11M | 0.34% | 54 |
|
|
2018
Q3 | $986M | Sell |
7,104,985
-350,874
| -5% | -$48.7M | 0.34% | 57 |
|
|
2018
Q2 | $925M | Sell |
7,455,859
-20,398
| -0.3% | -$2.53M | 0.41% | 41 |
|
|
2018
Q1 | $833M | Buy |
7,476,257
+360,010
| +5% | +$40.1M | 0.38% | 49 |
|
|
2017
Q4 | $850M | Buy |
7,116,247
+725,946
| +11% | +$86.7M | 0.39% | 50 |
|
|
2017
Q3 | $896M | Buy |
6,390,301
+215,005
| +3% | +$30.2M | 0.43% | 37 |
|
|
2017
Q2 | $751M | Buy |
6,175,296
+25,724
| +0.4% | +$3.13M | 0.38% | 48 |
|
|
2017
Q1 | $746M | Buy |
6,149,572
+454,069
| +8% | +$55.1M | 0.39% | 47 |
|
|
2016
Q4 | $697M | Buy |
5,695,503
+984,796
| +21% | +$120M | 0.38% | 49 |
|
|
2016
Q3 | $577M | Sell |
4,710,707
-1,315,068
| -22% | -$161M | 0.32% | 64 |
|
|
2016
Q2 | $704M | Buy |
6,025,775
+728,182
| +14% | +$85M | 0.41% | 48 |
|
|
2016
Q1 | $738M | Buy |
5,297,593
+92,063
| +2% | +$12.8M | 0.44% | 45 |
|
|
2015
Q4 | $993M | Sell |
5,205,530
-281,475
| -5% | -$53.7M | 0.58% | 33 |
|
|
2015
Q3 | $858M | Buy |
5,487,005
+531,317
| +11% | +$83.1M | 0.53% | 35 |
|
|
2015
Q2 | $896M | Buy |
4,955,688
+1,787,436
| +56% | +$323M | 0.51% | 36 |
|
|
2015
Q1 | $549M | Buy |
3,168,252
+674,172
| +27% | +$117M | 0.32% | 68 |
|
|
2014
Q4 | $461M | Sell |
2,494,080
-470,868
| -16% | -$87.1M | 0.27% | 86 |
|
|
2014
Q3 | $492M | Buy |
2,964,948
+180,277
| +6% | +$29.9M | 0.3% | 75 |
|
|
2014
Q2 | $435M | Buy |
2,784,671
+333,252
| +14% | +$52.1M | 0.26% | 96 |
|
|
2014
Q1 | $373M | Sell |
2,451,419
-191,599
| -7% | -$29.1M | 0.22% | 108 |
|
|
2013
Q4 | $352M | Buy |
2,643,018
+429,491
| +19% | +$57.1M | 0.21% | 115 |
|
|
2013
Q3 | $257M | Sell |
2,213,527
-206,583
| -9% | -$24M | 0.17% | 147 |
|
|
2013
Q2 | $223M | Buy |
+2,420,110
| New | +$223M | 0.15% | 152 |
|